Quorum sensing and biofilm formation

• US 7,427,408 B2
• Filed: 06/06/2002
• Issued: 09/23/2008
• Est. Priority Date: 06/06/2002
• Status: Active Grant

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Shi, Wenyuan, Anderson, Maxwell H., Merritt, Justin
• Primary Examiner(s): Tate; Christopher R.
• Application Number:
  US10/164,446
• Publication Number:
  US 20030229000A1
• Time in Patent Office: 2,301 Days
• Field of Search: 435/29, 435/4, 435/885, 424/244.1
• US Class Current: 424/405
• CPC Class Codes: A61K 38/1709 from mammals

Abstract

The present invention is based on the discovery that interspecies quorum sensing is related to biofilm formation. The present invention provides methods useful for treating or preventing biofilm formation and microbial infections associated with biofilm formation by using an agent that either increases LuxS-dependent pathway or interspecies quorum sensing signal. The present invention also provides compositions containing an anti-microbial agent and an agent that either increases LuxS-dependent pathway or interspecies quorum sensing signal.

Claims

1. A method of inhibiting or treating the formation of a biofilm comprising S. mutans on a surface, said method comprising contacting the surface with autoinducer-2 in an amount effective to increase Lux-S dependent signal pathway in a bacterium.

2. The method of claim 1, wherein the biofilm further comprises other Gram positive bacteria.

3. The method of claim 1, wherein the biofilm comprises more than one species of bacteria.

4. The method of claim 1, wherein the biofilm further comprises Streptococcus sp. other than S. mutans.

5. The method of claim 1, wherein the extracellular matrix of the biofilm is regulated by LuxS-dependent signal pathway.

6. The method of claim 1, wherein the surface is a solid surface.

7. The method of claim 1, wherein the surface is an epithelial or mucosal surface of a mammal.

8. The method of claim 1, wherein the surface is associated with bacterial infection.

9. A method of inhibiting or treating the formation of a biofilm comprising S. mutans on a surface, said method comprising contacting the surface with autoinducer-2 in an amount effective to increase an interspecies quorum sensing signal.

10. A method of treating a condition associated with formation of a biofilm comprising S. mutans, said method comprising administering to a subject in need of such treatment autoinducer-2 in an amount effective to increase LuxS-dependent signal pathway in a bacterium.

11. The method of claim 10, wherein the biofilm further comprises other Gram positive bacteria.

12. The method of claim 10, wherein the biofilm comprises more than one species of bacteria.

13. The method of claim 10, wherein the biofilm further comprises Streptococcus sp. other than S. mutans.

14. The method of claim 10, wherein the extracellular matrix of the biofilm is regulated by LuxS-dependent signal pathway.

15. A method of treating a condition associated with formation of a biofilm comprising S. mutans, said method comprising administering to a subject in need of such treatment autoinducer-2 in an amount effective to increase an interspecies quorum sensing signal.

16. A method of treating a condition associated with formation of a biofilm comprising S. mutans, said method comprising administering to a subject in need of such treatment a composition comprising an anti-microbial agent and autoinducer-2 in an amount effective to increase LuxS-dependent signal pathway in a bacterium.

17. The method of claim 16, wherein the condition is on an epithelial or a mucosal surface.

18. The method of claim 17, wherein the mucosal surface is selected from the group consisting of mouth, vagina, gastrointestinal tract, and esophageal tract.

19. The method of claim 16, wherein the condition is an oral infection.

20. The method of claim 16, wherein the condition is caused by S. mutans.

21. A method of treating a condition associated with formation of a biofilm comprising S. mutans, said method comprising administering to a subject in need of such treatment a composition comprising an anti-microbial agent and autoinducer-2 in an amount effective to increase an interspecies quorum sensing signal.

22. A method of treating a microbial infection associated with formation of a biofilm comprising S. mutans, said method comprising administering to a population of bacteria an anti-microbial agent and autoinducer-2 in an amount effective to increase LuxS-dependent signal pathway in a bacterium.

23. A method of treating microbial infection associated with formation of a biofilm comprising S. mutans, said method comprising administering to a population of bacteria an anti-microbial agent and autoinducer-2 in an amount effective to increase interspecies quorum sensing signal.

24. A method of treating formation of a biofilm comprising S. mutans on a surface comprising contacting the surface, said method with an anti-microbial agent and autoinducer-2 in an amount effective to increase LuxS-dependent signal pathway in a bacterium.

25. A method of treating formation of a biofilm comprising S. mutans on a surface comprising contacting the surface, said method with an anti-microbial agent and autoinducer-2 in an amount effective to increase interspecies quorum sensing signal.

26. A method of sensitizing bacteria for an anti-bacteria treatment comprising administering to a biofilm population of bacteria comprising S. mutans an amount of autoinducer-2 effective to increase LuxS-dependent signal pathway in a bacterium.

27. A method of sensitizing bacteria for an anti-bacteria treatment comprising administering to a biofilm population of bacteria comprising S. mutans an amount of autoinducer-2 effective to increase, interspecies quorum sensing signal.